Biocon to supply insulin under Malaysia MoH contracts worth over Rs. 515 crore
Partnership with Duopharma Biotech covers human insulin, insulin glargine and insulin aspart, supporting diabetes care and medicine security in Malaysia
Partnership with Duopharma Biotech covers human insulin, insulin glargine and insulin aspart, supporting diabetes care and medicine security in Malaysia
The collaboration comes at a time when access to high-quality fertility treatment remains uneven, despite rapid market expansion
The research underscores growing concern that the intersection of neurodevelopmental conditions and social disadvantage can significantly compound health risks across the life course
New digital platform provides global sponsors with live visibility into R&D, process development and GMP manufacturing operations, enhancing collaboration and decision-making
After a volatile decade in which approvals swung sharply from year to year, 2025’s total pushed past long-term norms, exceeding the 10-year average
The safety profile of the Lunsumio and Polivy combination was consistent with the known profiles of the individual study medicines
Clearing 19 biologics for Europe market
The move comes as demand rises for wider access to glaucoma screening and more flexible clinical workflows
As per union government, growing public participation reflects rising awareness and collective commitment towards advancing organ and tissue donation
The company said the safety profile remained consistent with earlier studies and was considered manageable
Subscribe To Our Newsletter & Stay Updated